Emalex Biosciences   Report issue

For profit Phase 1 Phase 3
Founded: Northbrook IL United States (2010)

Organization Overview

First Clinical Trial
2019
NCT04007991
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Emalex Biosciences Inc.